ADD/ADHD News

Children with ADHD, autism and other comorbid neurodevelopmental diagnoses who had well-controlled ADHD medication use for 1 year had improved cognitive test scores and ADHD symptoms, according to a Journal of Psychiatric Research study.

Researchers reported that prenatal use of antipsychotics was not associated with risks for adverse outcomes in children — specifically, ADHD, autism spectrum disorder, preterm birth or being born small for gestational age.

The assumption that half of childhood ADHD cases remit by adulthood may be inaccurate, as symptoms fluctuate into adulthood in most cases, according to results of a multimodal treatment study published in American Journal of Psychiatry.

Lisdexamfetamine significantly improved outcomes among adults with ADHD and comorbid sluggish cognitive tempo, according to results of a crossover trial published in Journal of Clinical Psychiatry.

Optimized dosing of delayed-release and extended-release methylphenidate increased children’s control of ADHD symptoms throughout the day, according to study results published in Journal of Clinical Psychiatry.

Several factors increased risk for stimulant treatment discontinuation and switch to nonstimulants among people with ADHD, according to study results published in American Journal of Psychiatry.

Potential behavioral changes stemming from puberty were among the most common concerns of parents whose daughters presented for a premenarchal visit, researchers wrote in the Journal of Pediatric and Adolescent Gynecology.

Researchers conducted an umbrella review of interventions for mental disorders among youths that provided evidence-based information for clinical decision making.

Children with substantial externalizing symptoms who received ADHD medications had lower odds for suicidality, a cohort study showed.

Healio Psychiatry has compiled a list of its five most-viewed stories in May.